Assembly Biosciences (ASMB) vs MapLight Therapeutics (MPLT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
MapLight Therapeutics is the larger company by market cap ($490.7 million vs $479.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ASMB | MPLT |
|---|---|---|
| Share price | $23.53 | $8.83 |
| Market cap | $479.08M | $490.73M |
| 1-day change | +3.11% | -3.50% |
| YTD return | -32.90% | -47.91% |
| 1-year return | -10.51% | — |
| 5-year return | -41.67% | — |
| P/E ratio (TTM) | 22.63 | — |
| EPS (TTM) | $1.04 | $-6.25 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $39.71 | $40.43 |
| 52-week low | $21.80 | $8.71 |
| Distance from 52-week high | -40.75% | -78.16% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +120.99% | +200.57% |
| Average volume | 279.78K | 851.70K |
| Shares outstanding | 20.36M | 52.85M |
| Employees | 73 | 133 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Assembly Biosciences
ASMB stock →Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide. Its pipeline includes long-acting helicase-primase inhibitors candidates, including ABI-5366 and ABI-1179, which are in Phase 1 clinical studies for recurrent genital herpes; and ABI-6250, an orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical study for the treatment of chronic hepatitis delta virus (HDV) infection.
Health Care · Biotechnology: Pharmaceutical Preparations · 73 employees
About MapLight Therapeutics
MPLT stock →MapLight Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous system disorders.
Health Care · Biotechnology: Pharmaceutical Preparations · 133 employees
ASMB vs MPLT FAQ
Which is bigger, Assembly Biosciences or MapLight Therapeutics?
MapLight Therapeutics (MPLT) is larger, with a market capitalization of $490.73M compared with $479.08M for Assembly Biosciences (ASMB).
Are Assembly Biosciences and MapLight Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.